Analyst Ratings Published 10/07/2025, 09:30 pm 0 Goldman Sachs resumes Immunovant stock coverage with Neutral rating IMVT -1.75% ...

Jefferies analyst Roger Song maintained a Buy rating on TG Therapeutics with a price target of $46.00, citing the company’s solid financial position with $276.2 million in cash and equivalents as of ...

Investing.com - Goldman Sachs (NYSE: GS) has resumed coverage on CG Oncology (NASDAQ: CGON) with a Buy rating and a price target of $40.00 on Thursday. The stock, currently trading at $27.04, appears ...

Investing.com - Goldman Sachs (NYSE: GS) has resumed coverage on Rhythm Pharmaceuticals (NASDAQ: RYTM) with a Buy rating and a price target of $97.00. The stock, currently trading at $89, has shown ...

Analyst Ratings Published 10/07/2025, 12:16 0 Halozyme stock resumes coverage at Goldman Sachs with Neutral rating HALO 1.40% ...

Analyst Ratings Published 07/10/2025, 07:14 AM 0 Harmony Biosciences stock resumes coverage at Goldman Sachs with Neutral rating HRMY -3.38% ...

Donald Trump is considering sending another Patriot air-defence system to Ukraine despite the US military having a shortage of missiles for the launcher.

On dynamic self-organization: examples from magmatic and other geochemical systems Rabih F. Sultan *; Abdel-Fattah; M. Abdel-Rahman † Departments of Chemistry and Geology†, American University of ...

Analyst Ratings Published 02-07-2025, 11:28 am 0 Citi resumes WiseTech Global stock coverage with Buy rating on Cargowise potential WTC 0.00% ...

American Airlines flights have resumed after a system outage grounded flights. Multiple reports on social media said planes were unable to take off because of technical problems.